Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients-Reference-Cited by-同舟云学术

Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients

Published:2003-03 Issue:3 Volume:55 Page:270-277
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Lee How Sung,Goh Boon Cher,Fan Lu,Khoo Yok Moi,Wang Lingzhi,Lim Robert,Ong Ai Bee,Chua Charlotte

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.2003.01767.x/fullpdf

Reference33 articles.

1. The human CYP3A subfamily: Practical considerations;Wrighton;Drug Metab Rev,2000

2. Metabolism of cyclosporin A; IV. Purification and identification of the rifampicin-inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of P450IIIA gene subfamily;Combalbert;Drug Metab Dispos,1989

3. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450;Watkins;J Clin Invest,1989

4. Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4;Kronbach;Mol Pharmacol,1989

5. Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidation drug metabolism;Guengerich;J Biol Chem,1986

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CYP3A Activity in End-of-Life Cancer Patients Measured by 4β-Hydroxycholesterol/cholesterol Ratio, in Men and Women;Cancers;2021-09-18

2. Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen;British Journal of Clinical Pharmacology;2014-08-21

3. CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients;The Journal of Clinical Pharmacology;2013-12-17

4. Ketoconazole Renders Poor CYP3A Phenotype Status With Midazolam as Probe Drug;Therapeutic Drug Monitoring;2006-04

5. Effect of CommonCYP3A4andCYP3A5Variants on the Pharmacokinetics of the CytochromeP450 3A Phenotyping Probe Midazolam in Cancer Patients;Clinical Cancer Research;2005-10-15